Immune & Antimicrobial
Psoriasin (S100A7)
Last updated
Dosing on file unverified
Not administered as therapeutic; observational only
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 8
-
human observational
NCT04622462: A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions With STRATICYTE graded on: an observational human design — “Observational”
-
human observational
NCT05853783: Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ graded on: a registered clinical study — “clinicaltrials.gov”
Not graded
6 citations whose study design could not be read from the title. Left ungraded rather than guessed at.
- not graded
- not graded
- not graded
- not graded
- not graded
- not graded
Identity
- UniProt
- P31151
Also called
- Psoriasin
Notes unverified prose
Endogenous peptide; no therapeutic dosing; biomarker in psoriasis and cholesteatoma; no human trials as drug; Endogenous; biomarker studies
Not on file 8
8 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- molecular weightnothing we hold supplies it
- molecular formulanothing we hold supplies it
- CAS registry numbernothing we hold supplies it
- PubChem identifiernothing we hold supplies it
- amino-acid sequencenothing we hold supplies it
- SMILES stringnothing we hold supplies it
- InChInothing we hold supplies it
- InChI keynothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.